Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taranjit S Gujral

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Science Signaling|October 22, 2009
Emerging miniaturized proteomic technologies to study cell signaling in clinical samplesTaranjit S Gujral, Gavin MacBeath
Iscience|May 21, 2020
Non-linear Deep Neural Network for Rapid and Accurate Prediction of Phenotypic Responses to Kinase InhibitorsSiddharth Vijay, Taranjit S Gujral
Iscience|October 2, 2018
KInhibition: A Kinase Inhibitor Selection PortalThomas Bello, Taranjit S Gujral
Plos One|April 13, 2010
A system-wide investigation of the dynamics of Wnt signaling reveals novel phases of transcriptional regulationTaranjit S Gujral, Gavin MacBeath
Oncogene|November 25, 2025
Beyond genomics: 3D microtumor assays for rapid, clinically relevant functional drug testingMarina Chan, Taranjit S Gujral
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2017
Hippo pathway mediates resistance to cytotoxic drugsTaranjit S Gujral, Marc W Kirschner
Annals of the New York Academy of Sciences|November 15, 2006
Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2Taranjit S Gujral, Lois M Mulligan
Cancer Research|December 14, 2021
Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory PhenotypeNao Nishida-Aoki, Taranjit S Gujral
Oncotarget|February 19, 2019
Emerging approaches to study cell-cell interactions in tumor microenvironmentNao Nishida-Aoki, Taranjit S Gujral
Iscience|May 2, 2022
Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapyYuqi Kang, Siddharth Vijay, Taranjit S Gujral
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Science Signaling|October 22, 2009
Emerging miniaturized proteomic technologies to study cell signaling in clinical samplesTaranjit S Gujral, Gavin MacBeath
Iscience|May 21, 2020
Non-linear Deep Neural Network for Rapid and Accurate Prediction of Phenotypic Responses to Kinase InhibitorsSiddharth Vijay, Taranjit S Gujral
Iscience|October 2, 2018
KInhibition: A Kinase Inhibitor Selection PortalThomas Bello, Taranjit S Gujral
Plos One|April 13, 2010
A system-wide investigation of the dynamics of Wnt signaling reveals novel phases of transcriptional regulationTaranjit S Gujral, Gavin MacBeath
Oncogene|November 25, 2025
Beyond genomics: 3D microtumor assays for rapid, clinically relevant functional drug testingMarina Chan, Taranjit S Gujral
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2017
Hippo pathway mediates resistance to cytotoxic drugsTaranjit S Gujral, Marc W Kirschner
Annals of the New York Academy of Sciences|November 15, 2006
Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2Taranjit S Gujral, Lois M Mulligan
Cancer Research|December 14, 2021
Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory PhenotypeNao Nishida-Aoki, Taranjit S Gujral
Oncotarget|February 19, 2019
Emerging approaches to study cell-cell interactions in tumor microenvironmentNao Nishida-Aoki, Taranjit S Gujral
Iscience|May 2, 2022
Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapyYuqi Kang, Siddharth Vijay, Taranjit S Gujral
Pageof 8